Study Shows no Evidence of a Mortality Benefit to PSA Screening

Source: JCNI: Journal of the National Cancer Institute

Follow this link for abstract

Date of publication: January 2012

Publication type: Journal article

In a nutshell: The study shows men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care.

Length of publication: Unknown

Some important notes: Please contact your local NHS Library for the full text of the article. Follow this link to find your local NHS Library.

This entry was posted on Monday, February 20th, 2012 at 11:58 am and is filed under Cancer screening, Journal article, Prostate cancer, Research, Screening, Volume 4 Issue 2. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a comment